APIMEDS PHARMACEUTICALS US I (APUS) is held by institutional investors who disclose positions via SEC 13F filings. View the full list of institutional holders on HoldingsIntel.

Are institutions buying or selling APUS?

HoldingsIntel tracks quarter-over-quarter changes in institutional positions for APIMEDS PHARMACEUTICALS US I, showing new buyers, position increases, decreases, and exits with conviction-weighted sentiment.

What is the Smart Money Verdict on APUS?

The Smart Money Verdict combines four independent signals (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for APIMEDS PHARMACEUTICALS US I.

Is institutional money flowing into APUS?

2 institutional investors hold APIMEDS PHARMACEUTICALS US I (APUS). View detailed buyer/seller breakdown on HoldingsIntel.

What do hedge funds think about APUS?

Track institutional sentiment and conviction scores for APIMEDS PHARMACEUTICALS US I (APUS) including Smart Money Verdict and position changes on HoldingsIntel.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
GEODE CAPITAL MANAGEMENT, LLC	Increased	40,051(+14.8%)	$71,666	0.0%	-15.91%	16
UBS Group AG	Increased	4,187(+619.4%)	$7,491	0.0%	+12.08%	18
BANK OF AMERICA CORP /DE/	Exited	0(-100.0%)	$66	0.0%	-25.35%	0
JANE STREET GROUP, LLC	Exited	0(-100.0%)	$44,588	0.0%	-20.73%	0

APIMEDS PHARMACEUTICALS US I

Continue exploring

Other Healthcare stocks held by institutions

APIMEDS PHARMACEUTICALS US I

Continue exploring

Other Healthcare stocks held by institutions